Patients with idiopathic inflammatory myopathies suffer from worse self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort.

To conclude, IIM patients, especially those with underlying ILD, may be particularly predisposed to symptomatic COVID infection and dyspnoea on exertion 30 days post-COVID (Table 2). Hence, we interviewed patients with IIM from the MyoCite cohort to understand their clinical profile and severity, and outcomes by 30-day physical function after COVID-19 infection. [Extracted from the article]